Achyut Healthcare Limited (ACHYUT.BO)
INR 4.41
(0.0%)
INR 4.41
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.86 Million INR | -4.29% |
| 2022 | 5.07 Million INR | 142.32% |
| 2021 | 2.09 Million INR | 495.45% |
| 2020 | 352 Thousand INR | -75.96% |
| 2019 | 1.46 Million INR | 37.98% |
| 2018 | 1.06 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -158 Thousand INR | 0.0% |
| 2023 Q1 | 1.89 Million INR | -12.22% |
| 2023 Q4 | 1.62 Million INR | 42.01% |
| 2023 Q2 | 3.24 Million INR | 70.89% |
| 2023 FY | 4.86 Million INR | -4.29% |
| 2023 Q3 | 1.14 Million INR | -64.77% |
| 2022 Q3 | 1.22 Million INR | -50.32% |
| 2022 Q2 | 2.47 Million INR | 0.0% |
| 2022 FY | 5.07 Million INR | 142.32% |
| 2022 Q1 | 2.47 Million INR | 271.28% |
| 2022 Q4 | 2.16 Million INR | 75.9% |
| 2021 Q1 | 3.16 Million INR | 0.0% |
| 2021 FY | 2.09 Million INR | 495.45% |
| 2021 Q4 | 665.8 Thousand INR | 39.43% |
| 2021 Q3 | 477.5 Thousand INR | -92.38% |
| 2021 Q2 | 6.26 Million INR | 98.18% |
| 2020 FY | 352 Thousand INR | -75.96% |
| 2019 FY | 1.46 Million INR | 37.98% |
| 2018 FY | 1.06 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 99.977% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | 99.688% |
| Sigachi Industries Limited | 2 Billion INR | 99.757% |
| Bal Pharma Limited | 770.19 Million INR | 99.369% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 99.922% |
| Medico Remedies Limited | 262.14 Million INR | 98.146% |
| Lasa Supergenerics Limited | 121.02 Million INR | 95.984% |
| Venus Remedies Limited | 2.18 Billion INR | 99.777% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 100.807% |
| Alpa Laboratories Limited | 188.89 Million INR | 97.427% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 99.836% |
| Shilpa Medicare Limited | 3.54 Billion INR | 99.863% |
| Aarti Drugs Limited | 8.31 Billion INR | 99.942% |
| Lupin Limited | 123.71 Billion INR | 99.996% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 99.997% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.996% |
| Windlas Biotech Limited | 1.33 Billion INR | 99.637% |
| Suven Life Sciences Limited | -200.79 Million INR | 102.421% |
| Eris Lifesciences Limited | 10.42 Billion INR | 99.953% |
| Valiant Laboratories Limited | -60.66 Million INR | 108.013% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 99.979% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | 99.436% |
| Ipca Laboratories Limited | 29.8 Billion INR | 99.984% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 99.868% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.998% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 99.67% |
| RPG Life Sciences Limited | 2.48 Billion INR | 99.804% |
| Mankind Pharma Limited | 44.52 Billion INR | 99.989% |
| Laurus Labs Limited | 24.62 Billion INR | 99.98% |
| Piramal Pharma Limited | 24.47 Billion INR | 99.98% |
| Syncom Formulations (India) Limited | 942.39 Million INR | 99.484% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.99% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.982% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.993% |
| Unichem Laboratories Limited | 4.86 Billion INR | 99.9% |
| Sequent Scientific Limited | 2.97 Billion INR | 99.837% |
| Novartis India Limited | 1.32 Billion INR | 99.634% |
| Wanbury Limited | 1.73 Billion INR | 99.719% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 99.882% |
| Wockhardt Limited | 16.24 Billion INR | 99.97% |
| Themis Medicare Limited | 1.5 Billion INR | 99.677% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 99.255% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 99.975% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 99.961% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.997% |
| Divi's Laboratories Limited | 32.44 Billion INR | 99.985% |
| NATCO Pharma Limited | 25.73 Billion INR | 99.981% |
| Gufic Biosciences Limited | 4.16 Billion INR | 99.883% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 99.894% |
| Ind-Swift Limited | 2.17 Billion INR | 99.776% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 99.916% |
| FDC Limited | 8.33 Billion INR | 99.942% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | 97.478% |
| Granules India Limited | 16.79 Billion INR | 99.971% |
| Medicamen Biotech Limited | 495.49 Million INR | 99.019% |
| Alkem Laboratories Limited | 52.29 Billion INR | 99.991% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 99.922% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | 66.659% |
| Brooks Laboratories Limited | 65.62 Million INR | 92.592% |
| Megasoft Limited | 342.07 Million INR | 98.579% |
| ZIM Laboratories Limited | 1.26 Billion INR | 99.616% |
| Strides Pharma Science Limited | 14.38 Billion INR | 99.966% |
| Neuland Laboratories Limited | 8.24 Billion INR | 99.941% |
| Morepen Laboratories Limited | 6.16 Billion INR | 99.921% |
| Hikal Limited | 3.14 Billion INR | 99.845% |
| Indoco Remedies Limited | 6.04 Billion INR | 99.92% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 99.917% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 99.217% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | 99.309% |
| Hester Biosciences Limited | 1.27 Billion INR | 99.618% |